skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy

Journal Article · · Circulation
 [1];  [2]; ORCiD logo [1];  [1];  [1]; ORCiD logo [1]; ORCiD logo [3];  [3];  [3]; ORCiD logo [1];  [1]; ORCiD logo [1];  [3]; ORCiD logo [3]; ORCiD logo [1];  [3];  [1];  [3];  [1];  [3] more »;  [1];  [1];  [1] « less
  1. Stanford Univ., CA (United States). School of Medicine
  2. Univ. of Washington, Seattle, WA (United States)
  3. Stanford Univ., CA (United States)

Background: Hypertrophic cardiomyopathy (HCM) is a complex disease partly explained by the effects of individual gene variants on sarcomeric protein biomechanics. At the cellular level, HCM mutations most commonly enhance force production, leading to higher energy demands. Despite significant advances in elucidating sarcomeric structure–function relationships, there is still much to be learned about the mechanisms that link altered cardiac energetics to HCM phenotypes. Here, we test the hypothesis that changes in cardiac energetics represent a common pathophysiologic pathway in HCM. Methods: We performed a comprehensive multiomics profile of the molecular (transcripts, metabolites, and complex lipids), ultrastructural, and functional components of HCM energetics using myocardial samples from 27 HCM patients and 13 normal controls (donor hearts). Results: Integrated omics analysis revealed alterations in a wide array of biochemical pathways with major dysregulation in fatty acid metabolism, reduction of acylcarnitines, and accumulation of free fatty acids. HCM hearts showed evidence of global energetic decompensation manifested by a decrease in high energy phosphate metabolites (ATP, ADP, and phosphocreatine) and a reduction in mitochondrial genes involved in creatine kinase and ATP synthesis. Accompanying these metabolic derangements, electron microscopy showed an increased fraction of severely damaged mitochondria with reduced cristae density, coinciding with reduced citrate synthase activity and mitochondrial oxidative respiration. These mitochondrial abnormalities were associated with elevated reactive oxygen species and reduced antioxidant defenses. However, despite significant mitochondrial injury, HCM hearts failed to upregulate mitophagic clearance. Conclusions: Overall, our findings suggest that perturbed metabolic signaling and mitochondrial dysfunction are common pathogenic mechanisms in patients with HCM. These results highlight potential new drug targets for attenuation of the clinical disease through improving metabolic function and reducing mitochondrial injury.

Research Organization:
SLAC National Accelerator Lab., Menlo Park, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); American Recovery and Reinvestment Act; National Institutes of Health (NIH); National Institute of Diabetes and Digestive Kidney Diseases; National Institute of General Medical Sciences; American Heart Association; National Institute of Biomedical Imaging and Bioengineering
Grant/Contract Number:
AC02-76SF00515; 1S10RR026780-01; P30DK079626; DK056336; RM1GM131981; 17CSA33590101; 2RM1HG00773506; 2T32EB009035
OSTI ID:
1872400
Journal Information:
Circulation, Vol. 144, Issue 21; ISSN 0009-7322
Publisher:
American Heart Association, Inc.Copyright Statement
Country of Publication:
United States
Language:
English

References (98)

Overexpression of Mitochondrial Transcription Factor A Ameliorates Mitochondrial Deficiencies and Cardiac Failure After Myocardial Infarction journal August 2005
Automated tilt series alignment and tomographic reconstruction in IMOD journal February 2017
Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy journal June 2013
Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations journal May 2014
High-Resolution Respirometry for Simultaneous Measurement of Oxygen and Hydrogen Peroxide Fluxes in Permeabilized Cells, Tissue Homogenate and Isolated Mitochondria journal June 2015
GOplot: an R package for visually combining expression data with functional analysis: Fig. 1. journal May 2015
Molecular Mechanisms of Mitochondrial Autophagy/Mitophagy in the Heart journal April 2015
An ‘Omics’ Perspective on Cardiomyopathies and Heart Failure journal September 2016
Structural and biochemical evidence of mitochondrial depletion in pigs with hypertrophic cardiomyopathy journal June 2003
Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy journal December 2011
A Splicing Mutation in the Novel Mitochondrial Protein DNAJC11 Causes Motor Neuron Pathology Associated with Cristae Disorganization, and Lymphoid Abnormalities in Mice journal August 2014
Mitochondrial morphology, topology, and membrane interactions in skeletal muscle: a quantitative three-dimensional electron microscopy study journal January 2013
Optimized Analytical Procedures for the Untargeted Metabolomic Profiling of Human Urine and Plasma by Combining Hydrophilic Interaction (HILIC) and Reverse-Phase Liquid Chromatography (RPLC)–Mass Spectrometry* journal June 2015
Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy journal May 2009
Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy journal October 2010
Differences in Cardiac Energetics Between Patients With Familial and Nonfamilial Hypertrophic Cardiomyopathy journal March 2000
Mitochondrial autophagy in cardiomyopathy journal June 2016
Regulatory Interplay between Proton Motive Force, ADP, Phosphate, and Subunit ϵ in Bacterial ATP Synthase journal January 2007
Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy journal February 2002
Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice journal May 2011
Hypertrophic cardiomyopathy journal January 2013
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy journal September 2017
Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association journal March 2016
Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death journal February 2002
Disease Stage–Dependent Changes in Cardiac Contractile Performance and Oxygen Utilization Underlie Reduced Myocardial Efficiency in Human Inherited Hypertrophic Cardiomyopathy journal May 2017
Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? journal June 2005
Metabolomic Analysis of Pressure-Overloaded and Infarcted Mouse Hearts journal July 2014
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy journal March 2015
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy journal February 2003
Electron microscopy of myocardial tissue. A nine year review journal April 2001
Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience journal July 2017
Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation journal March 1970
Cardiac Lipotoxicity: Molecular Pathways and Therapeutic Implications journal March 2013
Uncoupling Protein 2 in Cardiovascular Health and Disease journal August 2018
Mechanical Unloading Promotes Myocardial Energy Recovery in Human Heart Failure journal June 2014
Spectrophotometric Assay for Complex I of the Respiratory Chain in Tissue Samples and Cultured Fibroblasts journal April 2007
Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy journal December 2018
Normal Values of Left Ventricular Mass Index Assessed by Transthoracic Three-Dimensional Echocardiography journal January 2016
Increased de novo ceramide synthesis and accumulation in failing myocardium journal July 2017
Cross-Platform Comparison of Untargeted and Targeted Lipidomics Approaches on Aging Mouse Plasma journal December 2018
Development and application of MIPAR™: a novel software package for two- and three-dimensional microstructural characterization journal April 2014
PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation journal November 2018
Computer Visualization of Three-Dimensional Image Data Using IMOD journal January 1996
Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics journal September 2020
Cardiac transplantation for hypertrophic cardiomyopathy associated with sengers' syndrome journal November 1995
The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils: Human cardiac myofibril mechanics and R403Q myosin journal July 2008
Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations journal February 2019
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity journal June 2019
The mitochondrial DNA mutation T12297C affects a highly conserved nucleotide of tRNALeu(CUN) and is associated with dilated cardiomyopathy journal April 2001
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy journal July 2002
Mechanisms of disease: hypertrophic cardiomyopathy journal October 2011
The kinetic properties of citrate synthase from rat liver mitochondria journal September 1969
Identification of a Gene Responsible for Familial Wolff–Parkinson–White Syndrome journal June 2001
Mitochondrial Targeted Antioxidant Peptide Ameliorates Hypertensive Cardiomyopathy journal June 2011
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data journal July 2010
QIL1 is a novel mitochondrial protein required for MICOS complex stability and cristae morphology journal May 2015
Ceramide Is Upregulated and Associated With Mortality in Patients With Chronic Heart Failure journal March 2015
Mutations in the gamma2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis journal May 2001
Hypertrophic cardiomyopathy journal June 2004
Regulation and function of AMPK in physiology and diseases journal July 2016
Heart Mitochondrial Proteome Study Elucidates Changes in Cardiac Energy Metabolism and Antioxidant PRDX3 in Human Dilated Cardiomyopathy journal November 2014
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy journal August 1999
The Molecular Genetic Basis for Hypertrophic Cardiomyopathy journal April 2001
Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease journal January 2014
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress journal April 2007
Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T journal September 2003
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy journal January 2021
Molecular, Cellular, and Functional Characterization of Myocardial Regions in Hypertrophic Cardiomyopathy journal May 2012
MiR‐451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC 1 journal September 2014
GAM: a web-service for integrated transcriptional and metabolic network analysis journal April 2016
Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction journal December 2011
Regulatory Networks Controlling Mitochondrial Energy Production in the Developing, Hypertrophied, and Diabetic Heart journal January 2002
Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin journal December 2016
Physiological Mitochondrial Fragmentation Is a Normal Cardiac Adaptation to Increased Energy Demand journal January 2018
Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure journal August 2009
Reactive oxygen species and vascular biology: implications in human hypertension journal October 2010
Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. journal April 1998
The pathophysiological role of mitochondrial oxidative stress in lung diseases journal October 2017
Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy journal May 2003
Metabolism in cardiomyopathy: every substrate matters journal March 2017
Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography journal January 2019
A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) journal September 1998
Activation of Autophagy Ameliorates Cardiomyopathy in Mybpc3 -Targeted Knockin Mice journal October 2017
Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure journal April 2012
R-92L and R-92W Mutations in Cardiac Troponin T Lead to Distinct Energetic Phenotypes in Intact Mouse Hearts journal September 2007
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial journal September 2020
Mitochondria and Reactive Oxygen Species journal June 2009
Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion journal May 2003
UCSF ChimeraX: Meeting modern challenges in visualization and analysis: UCSF ChimeraX Visualization System journal September 2017
Lipoxidation in cardiovascular diseases journal May 2019
Mechanical and Energetic Consequences of HCM-Causing Mutations journal October 2009
Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure journal June 2012
Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy journal November 1992
Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA journal September 2011
Cardiolipin and Mitochondrial Function in Health and Disease journal April 2014
Clinical Relevance of Biomarkers of Oxidative Stress journal November 2015
Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart Disease journal November 2011
Convolutional neural networks for automated annotation of cellular cryo-electron tomograms journal August 2017

Similar Records

Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice
Journal Article · Mon Jun 29 00:00:00 EDT 2015 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1872400

A mutation in the {beta}-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype
Journal Article · Fri Jan 01 00:00:00 EST 2010 · Biochemical and Biophysical Research Communications · OSTI ID:1872400

Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy
Journal Article · Thu Aug 15 00:00:00 EDT 2019 · Journal of Nuclear Cardiology (Online) · OSTI ID:1872400